Gene · 10189
Papers1,565
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,565
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting neuroblastoma by small-molecule inhibitors of human ALYREF protein: mechanistic insights using molecular dynamics simulations. | J Biomol Struct Dyn | 2024 | 37158061 | PubTator, text mining | PubMed |
| Effect of RNA-binding proteins on osteogenic differentiation of bone marrow mesenchymal stem cells. | Mol Cell Biochem | 2024 | 37072640 | PubTator, text mining | PubMed |
| Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. | Front Neurosci | 2023 | 38239833 | PubTator, text mining | PubMed |
| Gender gap-Gender-specific development in the field of obstetrics and gynecology in Germany in the last 20 years. | Front Med (Lausanne) | 2023 | 38155660 | PubTator, text mining | PubMed |
| TICRR serves as a prognostic biomarker in lung adenocarcinoma with implications in RNA epigenetic modification, DDR pathway, and RNA metabolism. | Front Oncol | 2023 | 38152367 | PubTator, text mining | PubMed |
| The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma. | Front Oncol | 2023 | 38148842 | PubTator, text mining | PubMed |
| Viruses and Cajal Bodies: A Critical Cellular Target in Virus Infection? | Viruses | 2023 | 38140552 | PubTator, text mining | PubMed |
| Intestinal Microbiome Changes and Clinical Outcomes of Patients with Ulcerative Colitis after Fecal Microbiota Transplantation. | J Clin Med | 2023 | 38137770 | PubTator, text mining | PubMed |
| The role of RNA modification in urological cancers: mechanisms and clinical potential. | Discov Oncol | 2023 | 38117350 | PubTator, text mining | PubMed |
| Gene expression profiling and protein-protein network analysis revealed prognostic hub biomarkers linking cancer risk in type 2 diabetic patients. | Sci Rep | 2023 | 38114687 | PubTator, text mining | PubMed |
| Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications. | Cell Commun Signal | 2023 | 38111040 | PubTator, text mining | PubMed |
| The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses. | J Transl Med | 2023 | 38071304 | PubTator, text mining | PubMed |
| Overexpression of TMEM150A in glioblastoma multiforme patients correlated with dismal prognoses and compromised immune statuses. | PLoS One | 2023 | 38055673 | PubTator, text mining | PubMed |
| NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication. | PLoS Pathog | 2023 | 38048324 | PubTator, text mining | PubMed |
| Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma. | Heliyon | 2023 | 38045198 | PubTator, text mining | PubMed |
| The role of post-transcriptional regulation in SARS-CoV-2 infection and pathogenicity. | Front Immunol | 2023 | 38035086 | PubTator, text mining | PubMed |
| Establishment of a new molecular subtyping and prognostic signature with m6A/m5C/m1A/m7G regulatory genes for hepatocellular carcinoma. | Heliyon | 2023 | 38027812 | PubTator, text mining | PubMed |
| Do RNA modifications contribute to modulation of immune responses in allergic diseases? | Front Allergy | 2023 | 38026133 | PubTator, text mining | PubMed |
| Plant-derived nanovesicles: harnessing nature's power for tissue protection and repair. | J Nanobiotechnology | 2023 | 38001440 | PubTator, text mining | PubMed |
| Insights into the regulatory role of RNA methylation modifications in glioma. | J Transl Med | 2023 | 37964279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10189/papers?page=9